Skip to content

Study · Measured the body's own peptide · 2018

1 result

A self-organized actomyosin drives multiple intercellular junction disruption and directly promotes neutrophil recruitment in lipopolysaccharide-induced acute lung injury.

Chen B, Yang Z, Yang C, Qin W, Gu J, Hu C, Chen A, Ning J, Yi B, Lu K

FASEB journal : official publication of the Federation of American Societies for Experimental Biology7 Jun 2018Cited by 14 (Europe PMC)

PMID29879372 (opens in a new tab)DOI10.1096/fj.201701506rr (opens in a new tab)PepBankPUB-29879372
Source linkPubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01AnimalEndogenous levelAnimal study (in vivo)Mechanism

    In an LPS-induced model of acute lung injury, the lung's own thymosin β4 level fell after LPS administration.

    In plain wordsIn an animal model of lung injury, the body's own thymosin beta‑4 in the lung fell after LPS.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    DecreasePulmonary thymosin beta-4 level after LPS
    Study

    n: not reported in source

    LPS-induced acute lung injury model
    Outcome group
    Inflammation markers · Respiratory

    Source sentences

    Summary
    Pulmonary levels of E-cadherin, vascular endothelial-cadherin, occludin, myosin phosphatase target subunit 1, and thymosin β4 were decreased
    1 context sentence
    Summary · context
    We investigated the dynamic alterations and roles of actomyosin in ALI in vivo and in vitro models induced by LPS.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.